(19)
(11) EP 1 221 971 A2

(12)

(88) Date of publication A3:
27.09.2001

(43) Date of publication:
17.07.2002 Bulletin 2002/29

(21) Application number: 00969296.3

(22) Date of filing: 22.09.2000
(51) International Patent Classification (IPC)7A61K 39/39, A61K 39/145, A61P 31/04, A61P 31/12, A61P 33/00, A61P 35/00
(86) International application number:
PCT/EP0009/366
(87) International publication number:
WO 0121/207 (29.03.2001 Gazette 2001/13)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 24.09.1999 GB 9922703
06.07.2000 GB 0016685

(71) Applicant: SmithKline Beecham Biologics SA
1330 Rixensart (BE)

(72) Inventors:
  • FRIEDE, MartinSmithKline Beecham Biologicals s.a.
    B-1330 Rixensart (BE)
  • HERMAND, PhilippeSmithkline Beecham Biologic. sa
    B-1330 Rixensart (BE)
  • HENERICKX, Veronique,GlaxoSmithKline Biologicals
    B-1330 Rixensart (BE)

(74) Representative: Privett, Kathryn Louise 
GlaxoSmithKlineCorporate Intellectual Property CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) USE OF THE COMBINATION OF POLYOXYETHYLENE SORBITAN ESTER AND OCTOXYNOL AS ADJUVANT AND ITS USE IN VACCINES